Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call summary and Q&A indicate positive sentiment. Strong financial metrics, including an EPS guidance raise, suggest optimism. Although there are some uncertainties in price-cost dynamics and bolt-on acquisitions, the focus on organic growth, recurring revenue, and AI-powered innovations are promising. The Q&A highlights robust performance in key areas like Fluke and gas detection. Overall, the strategic plan and positive trends outweigh concerns, leading to a positive stock price outlook.
Core Growth 3% in Q4, driven by solid execution and growth acceleration in the business.
Adjusted EBITDA Growth 8% in Q4, driven by operating leverage and organizational streamlining.
Adjusted EPS Growth 13% in Q4, driven by adjusted EBITDA growth and share repurchases.
Full Year Adjusted EPS $2.71, exceeding the high end of the guidance range of $2.63 to $2.67, representing over 12% year-over-year growth.
Share Repurchases $265 million in Q4, totaling $1.3 billion in the second half of 2025, reflecting confidence in value creation.
Total Revenue $1.1 billion in Q4, up 4.5% year-over-year on a reported basis and 3% on a core basis, driven by volume growth and solid performance across regions.
Adjusted Gross Margin 63% in Q4, down 150 basis points year-over-year due to product mix, tariffs, and growth investments.
Free Cash Flow $315 million in Q4 and $930 million for the full year, with free cash flow conversion on adjusted net income over 100%.
Intelligent Operating Solutions (IOS) Revenue Grew 5% on a reported basis and 4% on a core basis in Q4, driven by price, volume, and strong performance in professional instrumentation and gas detection.
Advanced Healthcare Solutions (AHS) Revenue $353 million in Q4, up 3% year-over-year and 1.6% on a core basis, with growth impacted by U.S. hospital capital expenditure deferrals but supported by SaaS-based software growth.
CertiFiber Max: Fluke launched a new data center testing solution with the fastest throughput in the industry, aiding in testing and validating complex fiber systems quickly and accurately.
ServiceChannel Product Release: The third major product release of the year went live, enhancing maintenance professional onboarding, work order visibility, compliance, and payment efficiency.
Targeted Investments in High-Growth Markets: Fluke and ASP expanded their sales teams in India, contributing to strong growth in the region. Industrial Scientific's expanded commercial coverage drove acceleration in EMEA.
Recurring Revenue Growth: Recurring revenue grew faster than consolidated revenue, driven by Fluke's maintenance software and AI-enhanced software capabilities across iOS and AHS segments.
Operational Execution: Delivered core growth of 3%, adjusted EBITDA growth of 8%, and adjusted EPS growth of 13% in Q4. Full-year adjusted EPS reached $2.71, exceeding guidance.
Cost Discipline and Streamlining: Achieved operational leverage and reduced costs through organizational streamlining and corporate cost discipline, contributing to adjusted EBITDA margin expansion.
Capital Allocation: Executed $1.3 billion in share repurchases in the second half of 2025, reflecting disciplined capital allocation priorities.
Fortive Accelerated Strategy: Focused on accelerating profitable organic growth, disciplined capital allocation, and building investor trust to deliver benchmark-beating shareholder returns.
Adjusted Gross Margin: Adjusted gross margin in the quarter was about 63%, down about 150 basis points from prior year, driven largely by product mix, the net effect of tariffs and countermeasures, and targeted growth investments in the AHS segment.
Advanced Healthcare Solutions (AHS) Segment: The AHS segment continues to face challenges due to reimbursement and funding policy changes, specifically the deferral of U.S.-based hospital capital expenditures. Adjusted gross margin in this segment was 56% in Q4, down from 58% in the prior year, driven by strategic investments to drive growth.
Tariffs and Countermeasures: The net effect of tariffs and related countermeasures negatively impacted adjusted gross margins, particularly in the Intelligent Operating Solutions (IOS) segment.
Government Demand for Procurement Solutions: Government demand for procurement and estimating solutions remains pressured compared to the strong growth seen post-COVID.
European Market Trends: While there were early signs of improvement in Europe, the growth is not yet a sustained trend, indicating potential instability in this market.
U.S.-Based Hospital Capital Expenditures: Deferral of U.S.-based hospital capital expenditures continues to impact the AHS segment, reflecting ongoing challenges in this area.
2026 Adjusted EPS Guidance: The company is initiating full-year 2026 adjusted EPS guidance of $2.90 to $3, representing approximately 9% year-over-year growth at the midpoint.
Core Revenue Growth: The company expects core revenue growth in the range of 2% to 3% for 2026.
Market Dynamics: The 2026 outlook assumes a continuation of the market dynamics experienced in Q4 2025.
Foreign Exchange Impact: FX is expected to be an approximately 300 basis point tailwind in Q1 2026, easing as the year progresses.
Adjusted Effective Tax Rate: The company is planning for a mid-teens adjusted effective tax rate on a full-year basis, with Q1 through Q3 in the high teens and Q4 in the high single digits to low double digits.
Net Interest Expense: The company is currently modeling a full-year net interest expense of just over $120 million for 2026.
Diluted Share Count: The current diluted share count is approximately 315 million shares, accounting for incremental share repurchases.
Capital Deployment Priorities: The company plans to invest in organic growth, pursue bolt-on M&A, return capital through share repurchases, and maintain a modest growing dividend, focusing on maximizing medium- to long-term shareholder value.
Dividend Policy: The company plans to maintain a modest growing dividend as part of its capital allocation priorities.
Share Repurchase Program: In the fourth quarter, the company executed an additional $265 million of share repurchases, bringing total second half repurchases to $1.3 billion. Approximately 26 million shares, or roughly 8% of diluted shares outstanding, were repurchased in the second half of 2025. An additional 2.5 million shares were repurchased after the end of the quarter, reducing the total diluted shares outstanding to approximately 315 million.
The earnings call summary and Q&A indicate positive sentiment. Strong financial metrics, including an EPS guidance raise, suggest optimism. Although there are some uncertainties in price-cost dynamics and bolt-on acquisitions, the focus on organic growth, recurring revenue, and AI-powered innovations are promising. The Q&A highlights robust performance in key areas like Fluke and gas detection. Overall, the strategic plan and positive trends outweigh concerns, leading to a positive stock price outlook.
The earnings call highlights strong financial performance with positive EPS guidance, revenue growth, and strategic share repurchases. The Q&A session reinforces confidence with recurring revenue growth and regional demand trends. Despite some uncertainties in guidance details, the overall sentiment is positive, supported by strategic focus on M&A and shareholder returns.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.